Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -9,336 | -5,651 |
| Depreciation Amortization | 47 | 28 |
| Other Working Capital | 1,070 | 63 |
| Other Operating Activity | 456 | 327 |
| Operating Cash Flow | $-7,763 | $-5,233 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -312 | -245 |
| Investing Cash Flow | $-312 | $-245 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | N/A | -13 |
| Common Stock Issued | N/A | 140 |
| Other Financing Activity | 23,434 | 23,311 |
| Financing Cash Flow | $23,434 | $23,438 |
| Beginning Cash Position | 108 | 108 |
| End Cash Position | 15,467 | 18,068 |
| Net Cash Flow | $15,359 | $17,960 |
| Free Cash Flow | ||
| Operating Cash Flow | -7,763 | -5,233 |
| Capital Expenditure | N/A | -245 |
| Free Cash Flow | -7,763 | -5,478 |